Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions

利用自动化细胞富集和浓缩工艺进行治疗性NK细胞的封闭式生产，可实现可扩展、稳健且经济高效的解决方案。